The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 338:1619-1621 May 28, 1998 Number 22
NextNext

Preventing Blindness in Premature Infants

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
In 1942 Terry reported a retinal vasculopathy causing blindness in premature infants.1 The condition was called retrolental fibroplasia, because a fibrovascular mass could be seen behind the crystalline lens. Hundreds of babies in the United States still become blind or visually handicapped each year from this disease, now known as retinopathy of prematurity.

Initially, the cause appeared to be excess oxygen. In the 1940s and 1950s, premature infants were treated with high concentrations of oxygen to keep them alive. In the absence of a noninvasive method of measuring blood oxygen saturation, there was no way to titrate the amount of . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.